Award NoticeAwarded

human-derived monoclonal antibodies (mAbs) and viral recombinant antigens (Ags)

DEPT OF DEFENSE · ARMY MED RES ACQ ACTIVITY

This notice records an award. Find active opportunities

Award Information

This solicitation resulted in an award to MAPP BIOPHARMACEUTICAL, INC. San Diego CA 92121 USA for approximately $2,000,000 on May 29, 2025. Similar contracts are typically issued by DEPT OF DEFENSE under 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Award Number: HT9425-25-D-0009
Award Amount: $2,000,000
Award Date: May 29, 2025
Awardee: MAPP BIOPHARMACEUTICAL, INC. San Diego CA 92121 USA

View full award details on USASpending.gov

Contract Details

Notice ID: HT9425-25-D-0009
Opportunity Type: Award Notice
Agency: DEPT OF DEFENSE
Sub-Agency: DEFENSE HEALTH AGENCY (DHA)
Office: ARMY MED RES ACQ ACTIVITY
Posted Date: Wednesday, June 4, 2025
Response Deadline: Not specified
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
PSC Code: 6550
Set-Aside: Full & Open Competition
Place of Performance: San Diego, CA, 92121, USA
Status: Awarded

View on SAM.gov

Description

Mapp Biopharmaceutical, Inc. received a Firm Fix Price Sole Source IDIQ award for the delivery of human-derived monoclonal antibodies (mAbs) and viral recombinant antigens (Ags) in support of the United States Army Medical Research Institute of Infectious Diseases (USAMRIID).